Intranasal Azelastine and Fluticasone combination in the treatment of adolescents with Allergic Rhinitis
- Conditions
- Allergic rhinitis, unspecifiedAdolescentJ30.4M01.060.057
- Registration Number
- RBR-6pswj7
- Lead Sponsor
- Hospital São Paulo - Universidade Federal de São Paulo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Adolescents between 12 and 18 years old; both genders; difficult to control moderate-severe persistent allergic rhinitis diagnosis; positive cutaneous immediate hypersensitivity test or specific serum IgE to inhalant allergens
Uncontrolled asthma; significant anatomical defects of the upper airway; systemic disease cognitive deficits; upper airways infection in the last 3 weeks; in use of systemic corticosteroid (last 30 days); in use of specific immunotherapy and immunosuppressants.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method